FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Bipartisan Bill on Interchangeable Biologics

Four U.S. Representatives introduce the Biologics Competition Act, a bipartisan bill that would order HHS to evaluate the process by which interchange...

latest-news-card-1
Human Drugs

GSK Will Seek Expanded Use for Jemperli

GSK says it plans to submit a BLA supplement by 7/1 after reporting interim results from a Phase 3 trial investigating Jemperli (dostarlimab) plus sta...

latest-news-card-1
Human Drugs

Labeling Changes Approved for 2 Hedgehog Inhibitors

FDA approves changes to labeling for two Hedgehog inhibitors covering musculoskeletal adverse reactions and creatine kinase monitoring as requested in...

latest-news-card-1
Medical Devices

Guide on Animal Studies for Devices

FDA publishes a final guidance entitled General Considerations for Animal Studies Intended to Evaluate Medical Devices.

latest-news-card-1
Biologics

Under Protest, Brainstorm Resubmits BLA for NurOwn

BrainStorm Cell Therapeutics says it has refiled a BLA under the agencys file-over-protest procedure for NurOwn, a stem cell therapy for treating amyo...

latest-news-card-1
Human Drugs

FDA Resumes Generic Drug In-person Meetings

FDA says that it is now resuming generic in-person face-to-face meetings with generic drug industry members in a phased-in approach while also allowin...

latest-news-card-1
Medical Devices

Alternative 510(k) Pathway for Contact Lenses

FDA makes available a final guidance entitled Soft (Hydrophilic) Daily Wear Contact Lenses Performance Criteria for Safety and Performance Based Path...

latest-news-card-1
Medical Devices

Vaporox Next-gen Wound Healer Cleared

FDA clears a Vaporox 510(k) for its next-generation VHT-200 medical device system for healing chronic wounds.

latest-news-card-1
Biologics

Iovance Biotherapeutics BLA for Melanoma Therapy

Iovance Biotherapeutics files a rolling BLA submission for lifileucel, a tumor infiltrating lymphocyte therapy for treating certain patients with adva...

latest-news-card-1
Federal Register

Draft Guide on Cancer Drug Accelerated Approvals

Federal Register notice: FDA posts a draft guidance entitled Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics.